Skip to content

FARMAFENDER

Active Private limited companyfounded 2009active for 17 yearsPierlapont 88, 8210 ZedelgemKBO/BCE: BE 0819.991.676

Lifetime

16 annual accounts with figures on one time axis
peak of €95,126 in 2025
€95,126▲ 23.8%
lowest -€7,262 in 2015
€70,343▲ 52.8%
peak of €169,514 in 2025
€169,514▲ 22.7%
€100,366▲ 80.9%
Board1 name since 2009
1 director
Documentsfilings and deeds
23-07-20268 days before the deadline
2025micro format
Gross margin from €76,818 to €95,126Result from €46,039 to €70,343Dividend €39,027Equity from €138,199 to €169,514Debts from €55,482 to €100,366Cash from €10,385 to €16,186

Key points

from the 2025 annual accounts

Equity

€169,514 ▲ 22.7%

FARMAFENDER has made a profit without a break since 2016.

Filings

16 annual accounts since 2010
AprilJune31 JulyOctober2010201520202025

Two of the last ten came late. The 2019 accounts came in latest, 20 days after the end of the period.

Position in the sector

€70,343

Higher net result than 92% of companies in retail trade. The sector median is €4,724, over 25,359 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,726 companies had the same profile as FARMAFENDER has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,726 companies, not a prediction for FARMAFENDER. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0819991676
changes role from statutory manager to director “Het verlenen van adviezen van bedrijfseconomische, logistieke, commerciële, juridische, financiële, technische…” (deed in Dutch) · Discharge granted to · General meeting of 25-07-2024 · Gazette deed
Registered office moved from Sint-Michiels to Loppem The registered office moved from Rijselstraat 99, 8200 Sint-Michiels, België to Pierlapont 88, 8210 Loppem · Board meeting of 18-05-2022 · Gazette deed
Incorporation appointed as statutory manager · Founded by · Founded by · published on 30-10-2009 · Gazette deed
All 28 events

Comparable companies

same main activity, similar in size and age
Company
FARMAFENDER Zedelgem €269,880 €95,126 62.8% -
APOTHEEK HAVENDAM Bruges €263,053 €93,021 75.6% 0.8
NIMY PHAR Mons €259,917 €88,747 -72.9% -
PHARMACIE DU BLOCRY Wavre €293,441 €92,358 30.8% -
OOSTERAPOTHEEK Antwerp €275,743 €94,924 70.5% -
APOTHEEK PYLYSER SOFIE Alveringem €314,905 €80,857 26.9% -
Apotheek Sophie Dewulf Ypres €304,770 €123,658 56.3% -

These companies have the same main activity as FARMAFENDER: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €260,000 and €315,000, founded between 2007 and 2010.

Official details

Source: KBO
Status
Active since 21-10-2009Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 1 other
Establishment unit
2.219.382.6658210 Zedelgem, registered on 21-10-2009
Financial year end
31 December
Peppol
Reachable since 19-03-2025
Company details

Annual accounts 2025

≈ €460,000estimated
€269,880▲ 39.3%
Filing
Filed on 23-07-2026, 8 days before the end of the filing period
Financials

Insights on FARMAFENDER

FARMAFENDER files the micro format. That format states no turnover. The gross margin rose from €38,509 in 2010 to €95,126 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about FARMAFENDER

What is the company number of FARMAFENDER?
The company number of FARMAFENDER is 0819.991.676. The VAT number is the same number with BE in front: BE 0819.991.676.
Where is FARMAFENDER based?
The registered office is at Pierlapont 88, 8210 Zedelgem.Company details
What does FARMAFENDER do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of FARMAFENDER?
FARMAFENDER is a private limited company (BV).
When was FARMAFENDER founded?
FARMAFENDER was founded on 21-10-2009.
Is FARMAFENDER still active?
Yes, FARMAFENDER is an active enterprise in the KBO register.
What is the turnover of FARMAFENDER?
The turnover in financial year 2025 is about €460,000. This figure is estimated from the gross margin of €95,126 and 54 comparable companies (NACE 477). It probably lies between €230,000 and €660,000.Financials
Is FARMAFENDER profitable?
In financial year 2025, FARMAFENDER made a profit of €70,343.
Where can I find the annual accounts of FARMAFENDER?
FARMAFENDER filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of FARMAFENDER due?
FARMAFENDER must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.